Ebers Tech Inc is a private Canadian company backed by leaders from the financial sector focussed on the development of superior, differentiated cannabinoid products for a multitude of consumer product and therapeutic applications.

A unique approach

Ebers Pharma is a private company seeking to maximise the enormous therapeutic and commercial potential of cannabinoids through its unique approach:

  • Establishing a high-value Intellectual Property (IP) position within a commodity product
  • Ebers Pharma will leverage the safety and pharmacology of cannabinoids in more effective, differentiated & robustly protected products
  • Ebers Pharma will deliver value through two key channels:
    • NutraceuticalWellness & alternative medicine
    • PharmaceuticalNext generation of future prescribed cannabinoid therapies

Market Opportunity

$11BN

Legal cannabis market in USA expected to total $11BN in 2018

(1) According to Cowen Research

$23BN

Legal cannabis market in USA projected to total $23BN by 2022

(2) According to Arcview market research

$50BN

Us consumer demand estimated at $50BN, largely serviced by black market

33states

Medical cannabis now legal in 33 states

USA Market share 2017

Get in Touch